Outcomes following robotic radical nephrectomy: a single-center experience

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Technological advancements have reduced the invasiveness of surgical treatments for malignant renal neoplasms.
• Laparoscopic radical nephrectomy is a standard treatment for renal tumors.
• Robotic surgery is increasingly adopted in urological procedures.

Purpose of the Study:

• To evaluate the feasibility of robotic radical nephrectomy (RRN).
• To assess the safety of RRN.
• To determine the oncological outcomes of RRN for renal tumors.

Main Methods:

• Retrospective review of patient records who underwent RRN from September 2007 to March 2011.
• Patients with standard indications for radical nephrectomy were offered RRN.
• Intraoperative and postoperative parameters, including operative time, blood loss, complications, and oncological outcomes, were recorded.

Main Results:

• Twenty-three patients underwent RRN with a mean operative time of 132.7 minutes and mean blood loss of 270 ml.
• Most patients were discharged by postoperative days 1-3.
• After a mean follow-up of 29.4 months, no residual tumor, local recurrence, or metastasis was observed.

Conclusions:

• Robotic radical nephrectomy (RRN) is a feasible and safe procedure for managing renal tumors.
• RRN demonstrates favorable oncological outcomes in the short term.
• This minimally invasive approach offers a viable alternative for patients requiring radical nephrectomy.